
    
      Randomized control trial with control group receiving LARC at 6 weeks postpartum and the
      study group receiving LARC in the immediate or early postpartum period. Outcomes will be
      measured by those who receive or do not receive LARC either in the hospital after delivery
      versus 6 weeks postpartum in accordance with the study subjects' randomized designation.
      Secondary outcomes of bleeding profile and satisfaction will also be assessed.
    
  